Skip to main content
Clinical Trials/NCT06250361
NCT06250361
Not yet recruiting
Not Applicable

Identification of Factors ASsociaTed With a Delayed Diagnosis in Crohn's Disease: the FAST Study

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives0 sites600 target enrollmentFebruary 15, 2024
ConditionsCrohn Disease

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Crohn Disease
Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Enrollment
600
Primary Endpoint
Number of patient's visits to doctors between the appearance of the first symptoms and the diagnosis of the disease.
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this observational study is to determine the factors associated with a delayed diagnosis and/or an immediately complicated disease for CD patients.

A questionnaire will be completed by the patients, each questionnaire has a patient section and a physician section.

Detailed Description

Number of patients expected : at least 600, coming from all types of practices (ANGH (expert hospitals), GETAID (expert university hospitals) and CREGG (expert private practice)). Recruitment period : 1 year Primary endpoint : The primary endpoint is the description of the factors linked to: * The IBD * The patient (see patient questionnaire in annex 1) * The health care system * The patient's self-care Secondary endpoint : * Validation of the "red flags" in a prospective cohort. * Comparison with the EPIMAD population, especially the location and severity.

Registry
clinicaltrials.gov
Start Date
February 15, 2024
End Date
June 15, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Crohn's disease diagnosed less than a year prior to inclusion
  • Written consent
  • Age ≥ 18 years

Exclusion Criteria

  • Diagnosis of Crohn's disease more than one year before inclusion
  • Patient protected by the law
  • Patient without health cover

Outcomes

Primary Outcomes

Number of patient's visits to doctors between the appearance of the first symptoms and the diagnosis of the disease.

Time Frame: Day 1 from appearence of first symptoms and the diagnosis of the disease.

Number of patient's visits to doctors between the appearance of the first symptoms and the diagnosis of the disease.

Number of exams performed between the appearance of the first symptoms and the diagnosis of the disease.

Time Frame: Day 1 from appearence of first symptoms and the diagnosis of the disease.

Number of exams performed between the appearance of the first symptoms and the diagnosis of the disease.

Number of medical specialties consulted between the appearance of the first symptoms and the diagnosis of the disease.

Time Frame: Day 1 from appearence of first symptoms and the diagnosis of the disease.

Number of medical specialties consulted between the appearance of the first symptoms and the diagnosis of the disease.

Secondary Outcomes

  • Number of predictive factors associated with a delayed diagnosis(Day 1)

Similar Trials